An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Kalytera Therapeutics Israel, Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT03840512
- Locations
- 🇦🇺
St Vincent's Hospital Sydney - The Kinghorn Cancer Centre, Sydney, Australia
🇮🇱Davidof Cancer Center, Beilinson hospital, Rabin medical center, Petach Tikva, Israel
🇮🇱Hadassah Medical Center - Bone Marrow Transplantation Department, Cancer Immunotherapy and Immunobiology Research Center, Jerusalem, Israel
© Copyright 2024. All Rights Reserved by MedPath